Few High-Grade Soft Tissue Sarcoma Patients Receive Chemo
Percentage of STS patients receiving chemo driven by factors such as tumor size, income, facility type.
Sarcoma
Addition of Pazopanib to Neoadjuvant Chemo Found Highly Active in Adult, Pediatric Sarcoma
The study is a collaboration of pediatric, adult cooperative groups.
Histology-Tailored Neoadjuvant Chemotherapy Produces Limited Results in Multinational Study on High-Risk Soft Tissue Sarcoma
Histology-tailored neoadjuvant chemotherapy failed to show superiority compared with standard neoadjuvant chemotherapy in patients with high-risk STS.
Public Insurance Tied to Lower Cancer Survival in Young Patients
Findings seen among patients <40 years with bone or soft tissue sarcomas, regardless of disease stage.
Functional Outcomes Near Preoperative Levels After Surgery for Adult Soft Tissue Sarcoma
An analysis of how functional outcomes are measured in patients with soft tissue sarcoma revealed the efficacy of salvage surgery, and a need to improve frequency of FO measurements.
Kaposi Sarcoma Treatment Gets Breakthrough Therapy Designation
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Pomalyst (pomalidomide; Celgene) for the treatment of patients with Kaposi sarcoma.
Management of Recurrent Ewing Sarcoma: Challenges and Approaches
[OncoTargets and Therapy] This review addresses common questions facing the clinician and patient, and provide an update on new strategies for Ewing Sarcoma therapy.
Nontypical Formulation of Pazopanib Effective, and Safe With Diligent Monitoring
Two cases studies demonstrate whether crushed pazopanib is a feasible alternative for patients who cannot swallow the tablets whole.
Tumor Location, Histology Influence Clinical Outcomes of Primary Cardiac Sarcoma
A retrospective review revealed the association between tumor location, disease histology, and prognosis for patients with primary cardiac sarcoma.
Risk of Kaposi Sarcoma Supported by Its Evolving Clinicopathologic Characteristics
Antiretroviral therapy has led to a dramatic reduction in incidence of AIDS-related Kaposi sarcoma; however, changes in the disease may lead to a resurgence in its risk for people with HIV infection.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Sarcoma
